Amphion Innovations PLC (LON:AMP)

Amphion Innovations PLC (LON:AMP)

Share Price
0.18 p
0 (0.00 %)
Market Cap
£0.37 m
Proactive Investors - Run By Investors For Investors

Amphion Innovations PLC

Amphion builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.

Amphion has a significant shareholding in 7 Partner Companies developing proven technologi es targeting substantial commercial marketplaces, each in excess of $1 billion. Each...

Market: AIM:AMP
52-week High/Low: 1.95p / 0.15p
Sector: Technology Hardware & Equipment
Market Cap: £0.37 m
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Amphion Innovations PLC

Amphion Innovations PLC Snapshot

The Company’s Business and Methodology

Amphion’s business is the formation, development, operation and financing of market-leading life science and technology companies in partnership with corporations, governments, universities and entrepreneurs seeking to commercialize their intellectual property. Building upon two decades of disciplined investment and operating expertise, the building of numerous successful public and private companies, and over $20 billion in value creation, Amphion provides an opportunity to participate in both public and private early-stage investments, with a primary focus on life science and technology companies 

Amphion’s Value-Creation Process

The Directors believe that the key to Amphion’s success will be the continued pursuit of the management’s successful multi-phase process for value creation.

Through its experience in building more than 30 companies, the Management Team has developed a process which generally can be broken down into distinct phases. Set out below is a representation of Amphion’s value-creation process, showing the five key phases described in more detail.

Amphion Value Creation

For more information, click these pages


Track Record



Current Portfolio Summary (as of 28 June 2018) 
Partner Companies

Company Amphion
Company Description
RFID systems for a range of applications
Software platform for inter-enterprise integration
Medical imaging product company with a drug/device combination product
Developing solutions for the antibiotic crisis
private emarkets
Online energy trading marketplace
Nutrigenomics for health & wellness


Specialized Entity

Company Amphion
Intellectual Property Development
* As DataTern is 100% owned by Amphion, it is consolidated into Amphion’s financial statements.


Richard C. E. Morgan, Interim Chairman, Executive Director

Richard C. E. MorganOver the course of his career, Mr. Morgan has been directly involved in the start-up and development of more than 35 companies in the information technology, healthcare, and biotechnology industries. Mr. Morgan was a founder and CEO of Amphion Capital Partners LLC (the predecessor company to Amphion Innovations). He was also the Managing General Partner of Amphion Partners LLC (formerly known as Wolfensohn Partners, LP) a position which he retains, although the partnership is no longer active.

Before joining Wolfensohn, Mr. Morgan spent 15 years with Schroders plc, a British merchant bank, where he was a member of the board of the merchant bank and head of the Schroder Strategy Group, which he founded. Mr. Morgan, a British citizen, was raised in Kenya and educated in England. He graduated with a B. Engineering First Class Honors from the University of Auckland, New Zealand. In 1982 he completed the Advanced Management Program at the Harvard Business School.



Stephen Austin, Non-Executive Director

Stephen AustinStephen began his career practicing corporate law, latterly in the London office of US law firm Dechert LLP, before moving into finance as a director of Teather & Greenwood, then a leading small and mid cap broker where he acted as a Nominated Advisor and Broker.  He then co-founded the London based small cap broker Hybridan LLP where he was co-managing partner for four years.  He is currently the Chief Investment Officer of Plumtree Capital Limited, an FCA authorised and regulated firm, which originates and advises institutional investors on special situation investment opportunities.



Robert J. Bertoldi, Executive Director

Robert J. BertoldiPrior to his involvement with the Company, Mr. Bertoldi was a founder President and CFO of Amphion Capital Partners LLC (the predecessor company) and VennWorks LLC. Mr. Bertoldi is also a general partner of Amphion Partners LLC (formerly known as Wolfensohn Partners, LP). Prior to that, he served as Chief Financial Officer for James D. Wolfensohn, Inc. and Hambro America Inc.

He began his career at KPMG and left as a manager in the investment services department. Mr. Bertoldi received a B.A. in Accounting and Economics from Queens College, New York in 1976 and became a Certified Public Accountant in 1978. He is a member of the AICPA and NYSCPA.



Philip Tansey, Non-Executive Director

Robert J. BertoldiMr. Tansey is Non-Executive Director and Chairman of Amphion’s Audit Committee. He has extensive experience leading global operations in dynamic enterprises. In 2011 he joined Panmure Gordon as a main Board Executive Director from BGC Partners Inc. where he was Chief Control Officer. Over six years with Panmure Gordon he managed the day-to-day operation of the firm's infrastructure, its public accounts and significant transactions including acquisitions, restructurings and legal negotiations including a major turn-around and clean-up operation. He also acted as Company Secretary. 

Before joining BGC, he was a director within Deutsche Bank’s Office of Internal Controls. His career has also spanned Credit Suisse First Boston, where he was Chief Operating Officer of the bank’s fixed income and derivatives product control group. He is a qualified FCA and started after qualifying at Salomon Brothers.

Amphion Innovations US, Inc.
125 Park Avenue
25th Floor, Suite 2622
New York, NY 10017

Phone +1 (212) 210 6282
Email [email protected]

UK Media please contact:

Walbrook PR
4 Lombard Street
London EC3V 9HD

Anna Dunphy
Phone +44 (0)20 7933 8786
Email [email protected]
Registered Office
Amphion Innovations plc
First Names House
Victoria Road
Douglas, Isle of Man

Incorporated in the Isle of Man
Registration No. 011472V

Amphion Advisors

Board of Directors
Robert J. Bertoldi – Executive Director
Richard C.E. Morgan – Executive Director
Philip Tansey – Non-Executive Director 

Nominated Advisor to the Company
Panmure Gordon & Co.
One New Change 
London, EC4M 9AF

Broker to the Company
Panmure Gordon & Co.
One New Change 
London, EC4M 9AF

Joint Broker to the Company
Northland Capital Partners Limited
40 Gracechurch Street
2nd Floor 
London, EC3V OBT

Advisors to the Company as to English Law
Reed Smith
The Broadgate Tower
20 Primrose Street
London, EC2A 2RS

Advisors to the Company as to Isle of Man Law
Cains Advocates Limited
Fort Anne
Douglas, Isle of Man IM1 5PD

Cains Fiduciaries Limited
First Names House
Victoria Road
Douglas, Isle of Man IM2 4DF

Auditors to the Company
Heritage Court
41 Athol Street
Douglas, Isle of Man IM99 1HN

Neville Registrars Ltd.
Neville House
18 Laurel Lane
Halesowen, West Midlands B63 3DA

Public Relations UK
Walbrook PR 
4 Lombard Street
London EC3V 9HD

Columns Including AMP


Market Reports Including AMP

Video RSS



© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use